Literature DB >> 28597108

Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies.

Chunlai Zuo1, Vaibhav Chumbalkar1, Peter F Ells2, Daniel J Bonville3, Hwajeong Lee4.   

Abstract

BACKGROUND: Idiopathic noncirrhotic portal hypertension (INCPH) is associated with histologic changes secondary to obliterative portal venopathy without cirrhosis. We studied the prevalence of individual histological features of INCPH in liver biopsies obtained incidentally during unrelated elective procedures and in elective liver biopsies with the diagnosis of fatty liver disease.
METHODS: A total of 53 incidental liver biopsies obtained intraoperatively during unrelated elective procedures and an additional 28 elective biopsies with the diagnosis of fatty liver disease without portal hypertension and cirrhosis were studied. Various histologic features of INCPH were evaluated.
RESULTS: Shunt vessel (30%), phlebosclerosis (27%), increased number of portal vessels (19%) and incomplete septa (17%) were common in these liver biopsies after confounding factors such as co-existing fatty liver disease or fibrosis were excluded. At least one feature of INCPH was noted in 90% of the biopsies. Eight (10%) biopsies showed 5-6 features of INCPH. In total, 11 (14%) of 81 patients had risk factors associated with INCPH, including hypercoagulability, autoimmune disease, exposure to drugs, and infections. No patient had portal hypertension at the end of the follow-up.
CONCLUSION: The histologic features of INCPH are seen in incidental liver biopsies and fatty liver disease without portal hypertension. Ten percent of the biopsies show 5-6 features of INCPH without portal hypertension. Interpreting histologic features in the right clinical context is important for proper patient care.

Entities:  

Keywords:  Cholecystectomy; Elective procedure; Fatty liver; Gastric bypass; Idiopathic noncirrhotic portal hypertension (INCPH); Liver biopsy

Mesh:

Year:  2017        PMID: 28597108     DOI: 10.1007/s12072-017-9801-6

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  25 in total

1.  Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.

Authors:  Susan C Abraham; Patrick S Kamath; Bijan Eghtesad; Anthony J Demetris; Alyssa M Krasinskas
Journal:  Am J Surg Pathol       Date:  2006-11       Impact factor: 6.394

2.  Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Am J Gastroenterol       Date:  2013-04-02       Impact factor: 10.864

3.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

4.  Obliterative portal venopathy: portal hypertension is not always present at diagnosis.

Authors:  Dominique Cazals-Hatem; Sophie Hillaire; Marika Rudler; Aurélie Plessier; Valerie Paradis; Bertrand Condat; Claire Francoz; Marie-Hélène Denninger; François Durand; Pierre Bedossa; Dominique C Valla
Journal:  J Hepatol       Date:  2010-10-28       Impact factor: 25.083

5.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

Authors:  I R Wanless; E Nakashima; M Sherman
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

Review 6.  Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

Authors:  I R Wanless
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 8.  The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

Authors:  Ian R Wanless; Koji Shiota
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

9.  The normal adult human liver biopsy: a quantitative reference standard.

Authors:  A R Crawford; X Z Lin; J M Crawford
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

10.  Central portalization correlates with fibrosis but not with risk factors for nonalcoholic steatohepatitis in steatotic chronic hepatitis C.

Authors:  Hwajeong Lee; Sanaz Ainechi; Karen Dresser; Elizabeth M Kurian
Journal:  Int J Hepatol       Date:  2014-11-30
View more
  8 in total

1.  Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.

Authors:  Abhijit Chougule; Archana Rastogi; Rakhi Maiwall; Chhagan Bihari; Vikrant Sood; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-04-12       Impact factor: 6.047

Review 2.  Undiagnosed liver diseases.

Authors:  Emily Gao; Julian Hercun; Theo Heller; Sílvia Vilarinho
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

3.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Masayoshi Kage
Journal:  Hepatol Int       Date:  2017-09-13       Impact factor: 6.047

Review 4.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Maria Guido; Samantha Sarcognato; Diana Sacchi; Guido Colloredo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

Review 5.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 6.  Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.

Authors:  Angela Puente; Jose Ignacio Fortea; Carmen Del Pozo; Patricia Huelin; Maria Luisa Cagigal; Marina Serrano; Joaquin Cabezas; Maria Teresa Arias Loste; Paula Iruzubieta; Antonio Cuadrado; Susana Llerena; Carlos Lopez; Emilio Fábrega; Javier Crespo
Journal:  Cells       Date:  2019-11-24       Impact factor: 6.600

7.  Histologic Lesions of Porto-Sinusoidal Vascular Disease Following Phlebotomy in Hemochromatosis.

Authors:  Tony El Jabbour; Kelsey E McHugh; Deepa T Patil; Chunlai Zuo; Brandon H Koo; Sungeun Kim; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2020-02-01

8.  Interobserver study on histologic features of idiopathic non-cirrhotic portal hypertension.

Authors:  Michel Kmeid; Chunlai Zuo; Stephen M Lagana; Won-Tak Choi; Jingmei Lin; Zhaohai Yang; Xiuli Liu; Maria Westerhoff; M Isabel Fiel; Kajsa Affolter; Eun-Young K Choi; Hwajeong Lee
Journal:  Diagn Pathol       Date:  2020-10-23       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.